Skip to main content
Novartis
language-selector-globe
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
United States | English
    • About 
      • Novartis in Ireland 
      • Country Leadership Team 
      • Contact 
      Novartis office
      About
    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Education and Awareness 
      • Patient Resources 
      • Adverse Event Reporting 
      • Novartis Societal Impact 
      Happy family outdoors
      Patients and Caregivers
    • Healthcare Professionals 
      • Healthcare professional country resource 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      • Novartis Ireland travel and Expenses Guidance 
      Healthcare professional talking with patient.
      Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Environmental Sustainability 
      As a global company, Novartis has a great responsibility and an even greater opportunity to lead the world in creating a positive social change, embracing societal impact as a core business objective.
      ESG
    • News 
      • News Archive 
      • Stories 
      • Contacts 
      Working on a Tablet
      News
    • Careers 
      • Career Search 
      • Working in Novartis Ireland 
      • Learning and Development 
      • Early Talent 
      • How We Work 
      • Well-being 
      • Diversity & Inclusion 
      • Awards and Recognition 
      Careers
      Careers
    • Investors
      • Financial Data 
    • Coronavirus 
      covid 10 grey image_0_0
      Coronavirus
    Home

Stories

Story Navigation
  • All Topics
  • Education & Awareness
  • Corporate
  • People and Culture
icon
  • Elderly couple looking at papers
    Education Awareness
    Mar 17, 2022

    ‘We’ll See You’ Campaign - Urges Irish Public to Keep Eye Care Appointments and Be Vigilant for Signs of Age-Related Macular Degeneration

    Education Awareness
  • #holdfirm
    Corporate
    Mar 17, 2022

    Novartis Ireland is supporting #HoldFirm

    Corporate
  • Image of coronavirus
    Corporate
    Mar 17, 2022

    A visual tour of scientific strategies for combating coronavirus

    Corporate
  • Coronavirus microscopic image
    Corporate
    Mar 17, 2022

    Novartis Ireland providing a broad range of initiatives to respond to communities impacted by COVID-19

    Corporate
  • Trinity College Dublin
    Corporate
    Mar 17, 2022

    Novartis Partnership with Trinity Centre for People with Intellectual Disabilities

    Corporate
  • Group photo of Novartis Executives together with Federal Councillor Alain Berset in front of the Wall of Hope.
    Corporate
    Mar 17, 2022

    Novartis opens facility for innovative cell and gene therapies in Switzerland

    Corporate
  • Newborn grasping finger image
    Education Awareness
    Mar 17, 2022

    Visionary: Silke Mader has a vision for the care of premature infants and their parents

    Education Awareness
  • Group photo at the launch of MS Explored
    Education Awareness
    Mar 17, 2022

    MS Explored - An Informational Meeting for Young People Living with Multiple Sclerosis in Ireland

    Education Awareness
  • EPIS group photo of attendees
    Education Awareness
    Mar 17, 2022

    4th annual European Patient Innovation Summit #EPIS

    Education Awareness
  • Novartis and Microsoft AI Collaboration
    Corporate
    Mar 17, 2022

    Novartis and Microsoft announce collaboration to transform medicine with artificial intelligence

    Corporate
  • AMD_Week_2019_Deirdre_O'Kane
    Education Awareness
    Mar 17, 2022

    National tour launched to highlight the symptoms of Age-Related Macular Degeneration with new online Symptom Checker

    Education Awareness
  • Louise O'Sullivan and Patrick Little holding the My Migraine Voice Report
    Education Awareness
    Mar 17, 2022

    Novartis Ireland launch My Migraine Voice Survey Report in Cork

    Education Awareness

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • › Next page

Novartis Ireland

Navigate Novartis
  • Patients and Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • News Archive
  • Stories
Other Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2025 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
Site intended for audiences in Ireland IE417033 March 24